Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical diagnostic laboratory tests

This article was originally published in The Gray Sheet

Executive Summary

Negotiated rulemaking committee is expected to meet for the final time Aug. 30-31 in Washington, D.C. to allow members to consider comments on HCFA's proposed rule embodying national coverage decisions for 23 tests or groups of tests (1"The Gray Sheet" Feb. 1, p. 3). A Federal Register notice announcing the meeting is expected to publish in the next few weeks

You may also be interested in...

Negotiated Rulemaking Group To Meet Once More To Review Proposed Rule

After nine meetings, the Negotiated Rulemaking Committee on Clinical Diagnostic Laboratory Tests has agreed in principle on 23 national Medicare coverage and administrative policies. However, members also decided during their contentious Jan. 25-27 gathering in Washington, D.C. to meet one last time July 12-13 to approve and sign their final product, a proposed rule.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts